Caricamento...
Glycogen Synthase Kinase-3 Inhibitors as Potent Therapeutic Agents for the Treatment of Parkinson Disease.
[Image: see text] Parkinson's disease (PD) is a devastating neurodegenerative disorder characterized by degeneration of the nigrostriatal dopaminergic pathway. Because the current therapies only lead to temporary, limited improvement and have severe side effects, new approaches to treat PD need...
Salvato in:
| Autori principali: | , , , , , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Chemical
Society
2012
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3582296/ https://ncbi.nlm.nih.gov/pubmed/23421686 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/cn300182g |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|